| Not yet recruiting | 2 | 152 | US | PARP inhibitor/Temozolomide, PARP inhibitor/TEMODAR, Lurbinectedin, Zepzelca | VA Office of Research and Development | Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | 12/29 | 12/30 | | |
| Recruiting | N/A | 6000 | US | Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes | University of Pittsburgh, National Institutes of Health (NIH) | Lung Cancer | 12/50 | 12/50 | | |
